These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2640548)

  • 1. Incidence of hepatotoxicity in children receiving isoniazid chemoprophylaxis.
    Nakajo MM; Rao M; Steiner P
    Pediatr Infect Dis J; 1989 Sep; 8(9):649-50. PubMed ID: 2640548
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver enzyme disturbances during isoniazid chemoprophylaxis in children.
    Beaudry PH; Brickman HF; Wise MB; MacDougall D
    Am Rev Respir Dis; 1974 Nov; 110(5):581-4. PubMed ID: 4429254
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatotoxicity and transaminase measurement during isoniazid chemoprophylaxis in children.
    Palusci VJ; O'Hare D; Lawrence RM
    Pediatr Infect Dis J; 1995 Feb; 14(2):144-8. PubMed ID: 7746698
    [No Abstract]   [Full Text] [Related]  

  • 4. Isoniazid hepatotoxicity and acetylation during tuberculosis chemoprophylaxis.
    Myles RK
    Am Rev Respir Dis; 1980 Sep; 122(3):505-6. PubMed ID: 6106445
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatotoxicity of rifampicin and isoniazid in children treated for tuberculosis.
    Linna O; Uhari M
    Eur J Pediatr; 1980 Sep; 134(3):227-9. PubMed ID: 6968680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid chemoprophylaxis. Association with detection and incidence of liver toxicity.
    Byrd RB; Horn BR; Griggs GA; Solomon DA
    Arch Intern Med; 1977 Sep; 137(9):1130-3. PubMed ID: 332099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated transaminases are common in children on prophylactic treatment for tuberculosis.
    Leeb S; Buxbaum C; Fischler B
    Acta Paediatr; 2015 May; 104(5):479-84. PubMed ID: 25619878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic effects of isoniazid in tuberculosis chemoprophylaxis. Role of biochemical monitoring in 1,000 patients.
    Byrd RB; Horn BR; Solomon DA; Griggs GA
    JAMA; 1979 Mar; 241(12):1239-41. PubMed ID: 762788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Isoniazid and the liver.
    Greenberg HB
    Am Rev Respir Dis; 1975 May; 111(5):708-9. PubMed ID: 1130761
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antitubercular chemoprevention: hepatotoxicity and therapeutic compliance].
    Hortoneda Giménez M; Alfonso Sánchez JL; Cortés Vizcaíno C; Sabater Pons A
    An Med Interna; 1993 Dec; 10(12):587-9. PubMed ID: 8049323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoniazid hepatotoxicity in children.
    Rapp RS; Campbell RW; Howell JC; Kendig EL
    Am Rev Respir Dis; 1978 Oct; 118(4):794-6. PubMed ID: 309296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoniazid liver injury during chemoprophylaxis in children.
    Spyridis P; Sinaniotis C; Papadea I; Oreopoulos L; Hadjiyiannis S; Papadatos C
    Arch Dis Child; 1979 Jan; 54(1):65-7. PubMed ID: 420524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprophylaxis of tuberculosis: when is the benefit worth the risk and cost?
    Moulding T
    Ann Intern Med; 1971 May; 74(5):761-70. PubMed ID: 5314806
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical hepatotoxicity of isoniazid in children.
    Stein MT; Liang D
    Pediatrics; 1979 Oct; 64(4):499-505. PubMed ID: 492816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced incidence of tuberculosis by prophylactic chemotherapy in subjects showing strong reactions to tuberculin testing.
    Ormerod LP
    Arch Dis Child; 1987 Oct; 62(10):1005-8. PubMed ID: 3674920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis prevention: cost-effectiveness analysis of isoniazid chemoprophylaxis.
    Rose DN; Schechter CB; Fahs MC; Silver AL
    Am J Prev Med; 1988; 4(2):102-9. PubMed ID: 3134928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of isoniazid-metabolizing enzyme genotypes and isoniazid-induced hepatotoxicity in tuberculosis patients.
    Sotsuka T; Sasaki Y; Hirai S; Yamagishi F; Ueno K
    In Vivo; 2011; 25(5):803-12. PubMed ID: 21753138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Remote results of antitubercular chemoprophylaxis and its present applications].
    Omodei Zorini A
    Ann Ist Super Sanita; 1968; 4(5):674-88. PubMed ID: 5734045
    [No Abstract]   [Full Text] [Related]  

  • 19. Isoniazid-associated hepatitis--serum enzyme determinations and histologic features.
    Lewis JE; Mello P; Knauer CM
    West J Med; 1975 May; 122(5):371-6. PubMed ID: 1130028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: The prevention of tuberculosis.
    Gregg DB
    J S C Med Assoc; 1974 Apr; 70(4):122-4. PubMed ID: 4523827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.